LYPLA1 silencing inhibited the proliferation, migration, and invasion of the NSCLC cells and was associated with increased E‐cadherin expression and decreased expression of the mesenchymal markers N‐cadherin, vimentin, and SNAIL. Here, LYPLA1 is linked to non-small cell lung carcinoma.